Cholesterol ester transfer protein in children on peritoneal dialysis

Yuriko Tanaka1, Takeshi Matsuyama, Kenji Ishikura

  • 1Department of Pediatrics, Fussa Hospital, Tokyo, Japan. yuriko@amy.hi-ho.ne.jp

Insights

Cholesterol ester transfer protein (CETP) activity is linked to lipid abnormalities in children undergoing peritoneal dialysis (PD). However, it does not explain the increased hyperlipidemia observed in younger patients with dyslipidemia.

Area of Science:

  • Biochemistry
  • Pediatric Nephrology
  • Lipid Metabolism

Background:

  • Dyslipidemia is a common complication in children on peritoneal dialysis (PD).
  • Cholesterol ester transfer protein (CETP) plays a role in lipoprotein metabolism and lipid transfer.
  • The specific contribution of CETP to dyslipidemia in pediatric PD patients remains unclear.

Purpose of the Study:

  • To investigate the association between CETP activity and mass with dyslipidemia in children on PD.
  • To determine if CETP activity or mass is responsible for more severe hyperlipidemia in younger PD patients.

Main Methods:

  • A cohort of 27 children on PD for over 6 months was studied.
  • Measurements included CETP activity, CETP mass, lipid profiles, apoprotein, and serum albumin.
  • Results were compared to a control group, with regression analyses used to examine relationships within the patient group.

Main Results:

  • Children on PD exhibited higher total cholesterol, triglycerides, LDL, VLDL, chylomicrons, and ApoB compared to controls.
  • While CETP activity did not differ significantly, CETP mass was lower in PD patients.
  • Specific CETP activity (activity/mass ratio) was significantly elevated in PD patients and correlated with atherogenic factors.

Conclusions:

  • Elevated specific CETP activity is associated with lipid abnormalities in pediatric PD patients.
  • CETP activity correlates with atherogenic factors but does not explain the severity of hyperlipidemia in younger children on PD.
Abstract

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...